Related references
Note: Only part of the references are listed.Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
Andreas Fischer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system
Daniel Rittirsch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier
Rana Al-Sadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
MicroRNA Regulation of Intestinal Epithelial Tight Junction Permeability
Dongmei Ye et al.
GASTROENTEROLOGY (2011)
Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium
Takuya Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanisms of Outside-in Signaling at the Tight Junction by Junctional Adhesion Molecule A
Eric A. Severson et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Mechanism of cytokine modulation of epithelial tight junction barrier
Rana Al-Sadi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Intestinal mucosal barrier function in health and disease
Jerrold R. Turner
NATURE REVIEWS IMMUNOLOGY (2009)
Formation of tight junction: determinants of homophilic interaction between classic claudins
Joerg Piontek et al.
FASEB JOURNAL (2008)
The density of small tight junction pores varies among cell types and is increased by expression of claudin-2
Christina M. Van Itallie et al.
JOURNAL OF CELL SCIENCE (2008)
Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-α-induced regulation of myosin light chain kinase gene activity
Dongmei Ye et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability
Rana Al-Sadi et al.
JOURNAL OF IMMUNOLOGY (2008)
JAM-A regulates permeability and inflammation in the intestine in vivo
Mike G. Laukoetter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
IL-1β causes an increase in intestinal epithelial tight junction permeability
Rana M. Al-Sadi et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-6 induces keratin expression in intestinal epithelial cells - Potential role of keratin-8 in interleukin-6-induced barrier function alterations
Lixin Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mechanism of glucocorticoid regulation of the intestinal tight junction barrier
Michel A. Boivin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier
DM Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo
DR Clayburgh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Treatment of Crohn's disease with anti-IL-6 receptor antibody
H Ito
JOURNAL OF GASTROENTEROLOGY (2005)
TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation
TY Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
IL-6 induces NF-κB activation in the intestinal epithelia
LX Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice
RK Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model
Y Tazuke et al.
PEDIATRIC SURGERY INTERNATIONAL (2003)
Intracellular IL-1 Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-κB pathways
C Garat et al.
CYTOKINE (2003)
Pathogenic role of interleukin-6 in the development of sepsis.: Part II:: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-α antibodies in a standardized murine contact burn model
N Pallua et al.
CRITICAL CARE MEDICINE (2003)
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial
EHS Choy et al.
ARTHRITIS AND RHEUMATISM (2002)
Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells
DD Hershko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Plasma levels of interlenkin-6 and interleukin-10 in preterm neonates evaluated for sepsis
C Romagnoli et al.
EUROPEAN JOURNAL OF PEDIATRICS (2001)
Increased expression of IL-16 in inflammatory bowel disease
D Seegert et al.
GUT (2001)
The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1 beta-stimulated human enterocytes
ES Hungness et al.
SHOCK (2000)
Share Paper
